Výsledky vyhledávání - "Arbinda Pokharel"

The Effect of Empagliflozin on Liver Fat in Type 2 Diabetes Mellitus Patients With Non-Alcoholic Fatty Liver Disease

Autor: Pukar Thapa, Arbinda Pokharel, Niyanta Karki, Rupesh Shrestha, Bikash Jaishi, Mukesh S Paudel, Sudhamshu Kc

Publikováno v: Cureus

Background and objective The prevalence of non-alcoholic fatty liver disease (NAFLD) is 60% in patients with type 2 diabetes mellitus (T2DM). NAFLD can lead to non-alcoholic steatohepatitis (NASH), both of which are the leading causes of cirrhosis. T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2efa524dd44c0eaad07aa005156992c
https://pubmed.ncbi.nlm.nih.gov/34466320

Zobrazit plný text záznamu

Estimation of Liver Fat by FibroScan in Patients With Nonalcoholic Fatty Liver Disease

Autor: Pukar Thapa, Rupesh Shrestha, Sudhamshu Kc, Niyanta Karki, Bikash Jaishi, Arbinda Pokharel

Publikováno v: Cureus

Background Assessment of nonalcoholic fatty liver disease (NAFLD) includes estimation of liver fat (steatosis). Controlled attenuation parameter (CAP) value obtained by FibroScan® (Echosens, Paris, France) is an alternative to liver biopsy for diagn

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c08517138bb6deb96f7a589113151e4c
http://europepmc.org/articles/PMC8367388

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání